FDA Safety Warning For Multaq, A Heart Rhythm Drug

Posted on December 20, 2011

According to news sources, the drug Multaq is getting a new safety warning after a study found increased risks of heart attack, stroke and death associated with the drug with a subset of patients that took part in the study.

The heart rhythm drug controls the heart’s chambers by allowing them to pump in sync for patients with atrial fibrillation. The new warning would allow the drug to remain on the market but would stress to doctors and patients that it be used only for treatment of the short-term variant of the condition. People with permanent atrial fibrillation were shown to double their risks of heart-related complications by using the drug.

The Food and Drug Administration has written the warning label with the drug-maker, Sanofli, urging doctors to check their patients heart rhythms once every three months to ensure that no adverse effects are taking place. As for patients who have the long term variant of the condition, the FDA is recommending that they discontinue the drugs use.

The FDA also said that the drug continues to be beneficial to patients.

As a personal injury lawyer Los Angeles, I appreciate all efforts being made to ensure increased drug safety standards for everyone . I hope this information can help raise awareness about this product and keep consumers safe. If you or a loved one has been injured through the use or consumption of a defective product, speak with a Los Angeles product liability lawyer to learn about the legal options available to you.

How Can We Help You?

If you have a legal matter you would like to discuss with an attorney from our firm, please call us at (310) 477-1700 or complete and submit the e-mail form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.

*Required Fields